The recent failure of metformin to improve metabolic control of obese adolescents with T1DM diabetes [60] illustrates a continuing unmet need for an adjunctive therapy like DDP-4 inhibitors that could reduce insulin requirements in type 1 diabetes. Here, INS is linked to type 1 diabetes mellitus.